NovaBridge Biosciences Balance Sheet
NovaBridge Biosciences's total assets for Q3 2025 were ¥1.97B, an increase of 855.44% from the previous quarter. NBP total liabilities were ¥131.67M for the fiscal quarter, a 1220.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.